探索糖尿病病的发病过程中的分子模式,重点关注潜在的治疗影响
Lyubomir Gaydarski1, Kristina Petrova1, Ivan Angushev1
1Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria.
糖尿病病 (DKD) 涉及复杂的分子通路,如 apelinergic 系统,VEGF/VEGFR 和 NO/NOS. 了解这些途径为管理DKD和改善糖尿病患者脏健康提供了新的治疗目标.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病病 (DKD) 是1型和2型糖尿病的主要并发症,导致慢性病 (CKD) 和末期病.
- 全球糖尿病患病率上升加剧了日益增长的DKD负担.
- 涉及到DKD病变的关键分子途径需要进一步阐明,以有效管理.
研究的目的:
- 在DKD中审查 apelinergic 系统,VEGF/VEGFR 轴和 NO/NOS 信号的作用.
- 探索针对这些分子通路的潜在治疗应用.
- 要突出这些系统在DKD病变发生过程中的复杂相互作用.
主要方法:
- 临床前和临床研究的文献综述.
- 对DKD背后的分子机制的分析.
- 综合当前对DKD路径参与的理解.
主要成果:
- 动系统具有双重作用,可能提供脏保护或加剧损伤.
- VEGF/VEGFR轴有助于球损伤和血管生成,需要仔细的治疗调制.
- 与氧化应激和炎症相关的NO/NOS系统活性变化是DKD的特征.
结论:
- 在DKD.中,阿比利内尔基系统,VEGF/VEGFR和NO/NOS之间的相互作用是复杂的.
- 针对这些途径为DKD治疗带来了挑战和机遇.
- 进一步的研究对于开发有效的DKD干预措施至关重要.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
相关概念视频
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Heart Failure Drugs: Diuretics
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
